AcuamarkDx Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Later Stage VC
- Investors
-
5
AcuamarkDx General Information
Description
Developer of a cancer screening blood technology designed to detect cancer markers at early stages. The company's technology integrates a suite of novel, multiplexed assays that test for several levels of molecular change through frequent, recurrent, sequential monitoring and screening, enabling doctors to get a scalable and economical blood-based screening result for early detection of cancer, heart disease, thyroid function, and diabetes.
Contact Information
Website
www.acuamarkdx.comCorporate Office
- 101 Avenue Of The Americas
- 3rd Floor (care of JLabs)
- New York, NY 10013
- United States
Corporate Office
- 101 Avenue Of The Americas
- 3rd Floor (care of JLabs)
- New York, NY 10013
- United States
AcuamarkDx Timeline
AcuamarkDx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC | 01-Apr-2026 | Completed | Clinical Trials - Phase 4 | |||
| 8. Later Stage VC (Series A2) | 04-Jun-2024 | Completed | Clinical Trials - Phase 4 | |||
| 7. Later Stage VC (Series A) | 06-Apr-2022 | Completed | Clinical Trials - Phase 4 | |||
| 6. Accelerator/Incubator | 01-Jan-2020 | Completed | Clinical Trials - Phase 4 | |||
| 5. Later Stage VC (Series AA) | 15-Dec-2019 | Completed | Pre-Clinical Trials | |||
| 4. Angel (individual) | 31-Dec-2018 | Completed | Pre-Clinical Trials | |||
| 3. Early Stage VC (Series AA) | 27-Dec-2017 | Completed | Pre-Clinical Trials | |||
| 2. Early Stage VC (Series A1) | 16-Nov-2016 | $1.6M | $1.6M | Completed | Startup | |
| 1. University Spin-Out | 16-Oct-2012 | Completed | Startup |
AcuamarkDx Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A2 | ||||||||
| Series AA3 | ||||||||
| Series AA2 | ||||||||
| Series AA1 | ||||||||
| Series A1 | 2,563,115 | $0.000100 | $1.33 | $1.33 | 1x | $1.33 | 6.69% | |
| Series A | 10,000,000 | $0.000100 | $1.67 | $1.67 | 1x | $1.67 | 26.11% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
AcuamarkDx Comparisons
Industry
Financing
Details
AcuamarkDx Competitors (23)
One of AcuamarkDx’s 23 competitors is Exact Sciences, a Formerly VC-backed company based in Madison, WI.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Exact Sciences | Formerly VC-backed | Madison, WI | ||||
| Delfi Diagnostics | Venture Capital-Backed | Palo Alto, CA | ||||
| GRAIL | Formerly VC-backed | Menlo Park, CA | ||||
| CellMax Life | Venture Capital-Backed | Sunnyvale, CA | ||||
| Freenome | Formerly VC-backed | Brisbane, CA |
AcuamarkDx Signals
AcuamarkDx Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 1955 Capital | Venture Capital | Minority | ||
| Bruker | Corporation | Minority | ||
| HBS Alumni Angels of Greater New York | Angel Group | Minority | ||
| XLerateHealth | Accelerator/Incubator | |||
| Cornell University | University |
AcuamarkDx FAQs
-
When was AcuamarkDx founded?
AcuamarkDx was founded in 2012.
-
Where is AcuamarkDx headquartered?
AcuamarkDx is headquartered in New York, NY.
-
What is the size of AcuamarkDx?
AcuamarkDx has 8 total employees.
-
What industry is AcuamarkDx in?
AcuamarkDx’s primary industry is Biotechnology.
-
Is AcuamarkDx a private or public company?
AcuamarkDx is a Private company.
-
What is AcuamarkDx’s current revenue?
The current revenue for AcuamarkDx is .
-
How much funding has AcuamarkDx raised over time?
AcuamarkDx has raised $25M.
-
Who are AcuamarkDx’s investors?
1955 Capital, Bruker, HBS Alumni Angels of Greater New York, XLerateHealth, and Cornell University have invested in AcuamarkDx.
-
Who are AcuamarkDx’s competitors?
Exact Sciences, Delfi Diagnostics, GRAIL, CellMax Life, and Freenome are some of the 23 competitors of AcuamarkDx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process